HOME >> BIOLOGY >> NEWS
Professor calls for a new branch of learning

Nanotechnology, the 'science of small things' is set to bring huge advantages in engineering, electronics, medicine and IT-- but the potential threats to health that widespread use of nanoparticles could bring need to be scrutinised, says a University of Edinburgh expert in this month's edition of Occupational and Environmental Medicine.

Professor Ken Donaldson, a lung toxicology expert and Professor of Respiratory Medicine at the University, calls for a new discipline--nanotoxicology-- to be built up, to address knowledge gaps and to help develop a safe nanotechnology. He wants guidelines to be developed to test all materials in the nanoscale where human health could be involved.

Professor Donaldson says: "We believe that efforts to untangle science and science fiction regarding the risks from nanotechnology are needed and that a focus on the potential harmful effects of nanoparticles is both timely and necessary. The importance of nanotechnology to the economy and to our future wellbeing is beyond debate, but its potential adverse impacts need to be studied along the same lines. A discipline of nanotoxicology would make an important contribution to the development of a sustainable and safe nanotechnology .

He added: "Our current knowledge of the toxicology of nanoparticles and nanotubes (tiny carbon tubes) is poor but suggests that nanoparticles may be able to have undesirable effects at their point of entry into the body, for example, the lungs, and might also be able to affect other organs. Nanoparticles in food may cross into the gut lymphatic system and so reach other organs more easily than larger particles do. Inhaled nanoparticles have been reported to travel from nasal nerves to the brain, a phenomenon seen with some viruses similar in size to nanoparticles."

Nanoparticles, materials the size of millionths of a millimetre, are already present in large numbers in the air from natural sources and from vehicle exhaust emissio
'"/>

Contact: Linda Menzies
linda.menzies@ed.ac.uk
44-131-650-6382
University of Edinburgh
30-Aug-2004


Page: 1 2

Related biology news :

1. Professor and student among tops in technology at UH
2. Professor publishes book on historic mosquito wars
3. Professor uses satellites to protect Amazon forests, global climate
4. Sarah Billington and Alexandria Boehm named Clare Boothe Luce Assistant Professors
5. Professor develops strategies to control exotic plant species
6. LSU Professor Emeritus wins 2001 National Wetlands Award
7. Professor says college athletic departments must pay more attention to eating disorders
8. Professor Will Connect With Students Live From China Dinosaur Site
9. Wistar Institute Professor Named First Koprowski Professor
10. Virginia Tech Fisheries Professor Works To Conserve Mussels
11. Professor Authors Complete Guide To Fungi

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Professor calls for new branch learning

(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... New Rochelle, NY -- The potential for clinical ... for transplant-based therapeutic strategies has previously been hindered ... the development of tumors. The ability to use ... for the treatment of heart disease, specifically acute ... Stem Cells and Development , a peer-reviewed ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: